First Manhattan CO Kiniksa Pharmaceuticals, Ltd. Transaction History

First Manhattan CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$8.15 - $15.88 $521,404 - $1.02 Million	-63,976 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$13.2 - $20.39 $342,804 - $529,528	25,970 Added 68.33%	63,976 $866,000
Q1 2019 Apr 12, 2019	BUY	$15.93 - $26.59 $605,340 - $1.01 Million	38,000 Added 633333.31%	38,006 $686,000
Q3 2018 Oct 15, 2018	BUY	$13.23 - $30.93 $79 - $185	6 New	6 $0

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $751M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.